- Home
- BTT vs TLRY Comparison
BTT vs TLRY Comparison
Compare BTT & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTT | TLRY |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BTT | TLRY |
|---|---|---|
| Price | $22.31 | $11.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $150.00 |
| AVG Volume (30 Days) | 151.1K | ★ 9.5M |
| Earning Date | 01-01-0001 | 01-09-2026 |
| Dividend Yield | ★ 2.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $830,766,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | N/A | $4.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.31 |
| 52 Week Low | $18.90 | $3.51 |
| 52 Week High | $21.86 | $23.20 |
Technical Indicators
Market Signals| Indicator | BTT | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 83.13 |
| Support Level | $22.49 | $7.10 |
| Resistance Level | $22.62 | $8.64 |
| Average True Range (ATR) | 0.17 | 0.74 |
| MACD | -0.01 | 0.76 |
| Stochastic Oscillator | 2.38 | 87.73 |
Price Performance
Historical ComparisonAbout BTT BlackRock Municipal 2030 Target Term Trust
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.